UroGen Pharma Ltd. (URGN)
9.38
-0.72 (-7.13%)
At close: Apr 10, 2025, 3:59 PM
9.39
0.05%
After-hours: Apr 10, 2025, 04:05 PM EDT
UroGen Pharma Revenue
UroGen Pharma reported an annual revenue of $90.4M, reflecting a 9.29% growth. For the quarter ending December 31, 2024, UroGen Pharma generated $24.57M in revenue.
Revenue (ttm)
$90.4M
Revenue Growth
9.29%
Price / Sales Ratio
5.05
Revenue / Employee
$384.67K
Employees
235
Market Cap
432.6M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | % Change |
|---|---|---|
| Dec 31, 2024 | 90.4M | +9.29% |
| Dec 31, 2023 | 82.71M | +28.52% |
| Dec 31, 2022 | 64.36M | +33.96% |
| Dec 31, 2021 | 48.04M | +307.17% |
| Dec 31, 2020 | 11.8M | n/a |